Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
iShare-Home Residential Smart Solar System: A Comprehensive and One-Stop Choice…
Furthermore, iShare-Home Residential Solar Energy Solution features a wide range of internal components and hardware that adhere to global industry standards. With multiple certifications for all components, customers can be confident they are receiving top-quality products. Additionally, Slenergy offers a complete line of warranties on all major products and components within our PV kits and solar energy solutions with optional extended warranties upon request. Furthermore, iShare-Home...
PR Newswire
20/11/2024
Experts Unveil 'Moments of Kalmfulness' Virtual Gallery: A Digital Retreat for…
In response, Kalms Herbal Remedies has partnered with mental health experts and renowned photographers to launch the Moments of Kalmfulness Virtual Gallery - an online collection of calming photography aimed at promoting mental well-being. In response, KalmsHerbal Remedies has partnered with mental health experts and renowned photographers to launch the Moments of Kalmfulness Virtual Gallery - an online collection of calming photography aimed at promoting mental well-being...
PR Newswire
20/11/2024
Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for…
Key Takeaways from the Celiac Disease Pipeline Report Key Takeaways from the Celiac Disease Pipeline Report Request a sample and discover the recent advances in celiac disease treatment drugs @ Celiac Disease Pipeline Report The celiac disease pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage celiac disease drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an...
PR Newswire
19/11/2024
Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key…
Key Takeaways from the Systemic Lupus Erythematosus Pipeline Report Key Takeaways from the Systemic Lupus Erythematosus Pipeline Report Request a sample and discover the recent advances in systemic lupus erythematosus treatment drugs @ Systemic Lupus Erythematosus Pipeline Report The systemic lupus erythematosus pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage systemic lupus erythematosus drugs, inactive and...
PR Newswire
19/11/2024
Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
19/11/2024
Preimplantation Genetic Testing Market Set to Reach $1.2 Billion by 2031, Driven…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204253 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204253 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Preimplantation Genetic Testing Market Overview 1. Market Definition and ScopePreimplantation Genetic Testing is a screening procedure used in conjunction with in vitro fertilization (IVF) to assess embryos for genetic...
PR Newswire
19/11/2024
Global Drug Discovery Technologies Market Projected to Reach $197 Billion by…
This report provides an in-depth analysis of the drug discovery technologies market, exploring trends from 2023, with estimates for 2024 and projections through 2029. It highlights the significant potential of technologies such as high-throughput screening (HTS), bioanalytical instruments, cell-based assays, genomics, bioinformatics, and proteomics, and the emerging fields of metabolomics and nanotechnology. The market is segmented by technology and application, including areas such as oncology…
PR Newswire
19/11/2024
Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing…
Dr Campbell Bunce, CSO and Cambridge Site Head at Abzena said, "We recognize that high-quality data is the cornerstone of effective decision-making. When it comes to early-phase biopharmaceutical programs, especially ADCs, developers must have a reliable CRO partner with the deep knowledge and technical capabilities required, and who can deliver the necessary data needed to successfully reach their next target inflection point." Dr Campbell Bunce, CSO and Cambridge Site Head at Abzena…
PR Newswire
19/11/2024
SKF confirms dates for CFO transition
Previous press release, 3 September 2024: [link] Previous press release,3 September 2024 : [ link ] Aktiebolaget SKF (publ) CONTACT: For further information, please contact:PRESS: Carl Bjernstam, Head of Media Relations tel: 46 31-337 2517; mobile: 46 722-201 893; e-mail:
[email protected]
INVESTOR RELATIONS: Sophie Arnius, Head of Investor Relations tel: 46 31-337 8072; mobile: 46 705-908 072; e-mail:
[email protected]
This information was brought...
PR Newswire
19/11/2024
Orion and Alligator Bioscience amend their agreement concerning two bispecific…
ORION CORPORATIONINVESTOR NEWS19 NOVEMBER 2024 at 18.30 EET Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodiesOrion Corporation and Alligator Bioscience AB have agreed on the conversion of the previously granted royalty-bearing license to Orion Corporation to two bispecific antibodies that the companies have been successfully developing in collaboration using Alligator's RUBY® bispecific format to a perpetual, fully paid,...
Nasdaq GlobeNewswire
19/11/2024
Health Canada Approves Aktiia Bracelet: First Consumer Blood Pressure Wearable…
How Does Aktiia's Bracelet Work?The precision monitoring device can take readings automatically whether users are awake or asleep, providing up to 800 measurements a month to understand what impacts blood pressure. How Does Aktiia's Bracelet Work?The precision monitoring device can take readings automatically whether users are awake or asleep, providing up to 800 measurements a month to understand what impacts blood pressure. These insights help users understand what impacts blood...
PR Newswire
19/11/2024
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to…
"We are honored to join forces with The Michael J. Fox Foundation, a true leader in driving research toward a cure for Parkinson's disease," said Yuling Luo, Founder, Chairman & CEO of Alamar Biosciences. "The comprehensive analysis of the PPMI cohort using our NULISAseq™ technology provides a unique opportunity to uncover new insights into disease mechanisms and accelerate the development of targeted therapies." "We are honored to join forces with The Michael J. Fox…
PR Newswire
19/11/2024
Meril Champions Innovation with Myval Octapro THV Launch at GISE 2024 & PCR…
The Myval THV series* has a profound impact & has been instrumental in advancing transcatheter aortic valve replacement (TAVR) therapy, making a significant positive impact on patients' lives. Characterized by reduced frame foreshortening leading to higher operator control and predictive deployment; availability of a large size matrix comprising of conventional, intermediate and extra-large valve diameters allowing better bioprosthetic valve sizing for individual patient and supported by a…
PR Newswire
19/11/2024
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 19 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and...
Nasdaq GlobeNewswire
19/11/2024
Boehringer's focus on Health Equity drives significant upgrade in Access to…
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the company's strategic shift of prioritizing Health Equity as its primary contribution to the United Nations Sustainable Development Goals (UN SDGs). Every two years the ATMI evaluates the efforts of the world's leading pharmaceutical companies and ranks the top 20 based on their efforts to...
Nasdaq GlobeNewswire
19/11/2024
Transpara Improves Cancer Detection by Decreasing False Negative Cancers
The false negative cancers detected by Transpara were all invasive and predominantly (82%) luminal A subtype. The luminal A breast cancer is the most common subtype, representing 50–60% of all breast cancers. In the Digital Breast Tomosynthesis (DBT) cohort, all of the interval cancers detected were in dense breasts. As dense breast tissue is often associated both with decreased mammographic sensitivity and increased individual risk, the ability of Transpara to detect these interval cancers…
PR Newswire
19/11/2024
TRACE International Releases the 2024 Bribery Risk Matrix
The updated 2024 matrix reveals substantial movement in scores across countries, with many improvements but also many deteriorations. Some of these changes are driven by the inclusion of new data, while others reflect a shift in components. About 90% of the data sources used to calculate matrix scores have provided an update in 2024, with only one data source, Transparency Index, featuring no updates. Most notably, the most recent World Bank Enterprise (WBES) survey included new economies in its…
PR Newswire
19/11/2024
Novartis ranks first in 2024 Access to Medicine Index
The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topics Novartis malaria access plans, widespread registration of products in LMICs, and inclusive business model to improve access to products in multiple countries were all highlighted as Best Practice across the industry Novartis has risen three places to secure the top spot on the 2024 Access to Medicine IndexBasel, November 19, 2024–...
Nasdaq GlobeNewswire
19/11/2024
Akari Therapeutics Regains Full Nasdaq Compliance
- Shareholders Equity Deficiency has been Cured -- Akari will Continue to be Listed and Traded on The Nasdaq Stock Market -BOSTON and LONDON, Nov.19, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) announces receipt of written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC informing the Company that its deficiency under Listing Rule 5550(b) has been cured. The Company is now in full compliance with all Nasdaq continued listing...
Nasdaq GlobeNewswire
19/11/2024
2024 Access to Medicine Index finds that pharma companies are missing…
Despite the pharmaceutical industry's evident potential to drive expansion of access to medicines, the 2024 Index results show that both product and geographic coverage remain inconsistent, leaving significant portions of the world's poorest populations overlooked and underserved. Despite the pharmaceutical industry's evident potential to drive expansion of access to medicines, the 2024 Index results show that both product and geographic coverage remain inconsistent, leaving significant...
PR Newswire
19/11/2024
TELUS Mental Health Index: Workers who are dissatisfied with their physical…
"There is a clear link between physical activity, employer support and employee wellbeing. At TELUS Health, we've seen that those employees whose physical health and wellbeing is supported by their employer have better mental health and higher productivity - outcomes for which every business owner strives" said Paula Allen, Global Leader, Research & Client Insights, TELUS Health. "This underscores the need for organizations to prioritize wellbeing as a strategic pillar of…
PR Newswire
19/11/2024
TELUS Mental Health: Physically active workers lose 12 fewer workdays of…
"There is a clear link between physical activity, employer support and employee wellbeing. At TELUS Health, we've seen that supported, active employees have better mental health and higher productivity - outcomes for which every business owner strives" said Paula Allen, Global Leader, Research & Client Insights, TELUS Health. "This underscores the need for organizations to prioritize wellbeing as a strategic pillar of business success. By integrating robust support systems…
PR Newswire
19/11/2024
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the…
ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, ultimately leading to muscle weakness and paralysis. ALS is an orphan disease, but its clinical course can be rapid with marked disability even at an early stage. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. The disease is always fatal, usually within five years of diagnosis. Few treatment options exist, resulting in a high unmet...
Nasdaq GlobeNewswire
19/11/2024
Digital Medicine Society Launches Resources to Navigate Global Digital Health…
DiMe's resources respond to uncertainty from developers about the requirements for and differences between pathways in Australia, China, England, France, Germany, Japan, South Korea, and the U.S. They include tools like country-specific regulatory guides, step-by-step flowcharts, and AI/ML guidelines that provide DHT developers with clear and actionable pathways to navigate requirements across diverse markets. DiMe's resources respond to uncertainty from developers about the requirements for...
PR Newswire
19/11/2024
Altri Comunicati